Clinical trial Recruiting at 2 sites Interventional Ages 21 and up

Palliative care education for dementia care providers in assisted living

Official title: Preparing Assisted Living Staff to Provider Palliative Care to Residents With Dementia: Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)

Run by University of South Florida · NCT06722352 · Data updated 2026-11-12

This study is testing whether training for nurses and caregivers in assisted living can improve the quality of care for people with dementia and make their jobs easier.

More Alzheimer Disease trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment792 (estimated)
SponsorUniversity of South Florida
Academic / other
Locations2 sites (Tampa, Florida and 1 other locations)
StatusRecruiting
StartedJanuary 28, 2025
Main results expectedDecember 1, 2028
Study endsAugust 1, 2029
Registry record updatedApril 29, 2026
Trial IDNCT06722352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are residents of assisted living facilities with a confirmed diagnosis of dementia and their caregivers.

Probably not a fit

Patients who do not have a dementia diagnosis or are not residing in participating assisted living facilities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on providing palliative care education to licensed nurses, administrators, and dementia care coordinators in assisted living communities. Over a four-week period, participants will engage in weekly training sessions aimed at improving the quality of dementia care outcomes. The study will involve a cluster randomized trial design across 30 assisted living facilities, with follow-ups at baseline, 3 months, and 6 months to assess the impact of the training on care outcomes for residents and their families. The study aims to enhance caregiver knowledge and reduce caregiver burden through structured education.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the quality of care for dementia patients and reduce caregiver burnout.

How similar studies have gone: Previous studies have shown that educational interventions for caregivers can lead to improved care outcomes, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

The AL community eligibility criteria include a minimum of 40+ beds and provide memory care services to at least 35% of their residents, and access to hospice services from Lifepath or Suncoast Hospice. The AL size of 40+ beds is selected so we will be able to recruit a minimum of 14 residents per site, based on the power analysis for the sample size of 450 for the primary study outcome of documentation of ACP discussions.

Residents are eligible if 1) they have a dementia diagnosis confirmed by the resident's physician (physician's signature required by University of South Florida (USF) Institutional Reiew Board (IRB) in prior clinical trial) regardless of dementia severity (mild, moderate, or severe), 2) if they have been admitted to the AL in the last month, and 3) if they have a legally responsible representative who understands English.

Staff are eligible if they are currently employed with the participating study AL as a registered/licensed practical nurse, administrator, or dementia care coordinator of a memory care unit and English speaking and 21 years of age or older.

Family members are eligible if 1) they are listed as the legally responsible party in the chart records for the resident with ADRD, 2) they understand English, and 3) are at least 21 years of age or older. This could include someone related to the person, a close friend or a legal guardian who oversees the person's care and is responsible for decisions about their care.

Exclusion Criteria:

AL sites will be ineligible if 1) the are not a licensed Florida assisted living facility; 2) they have previously participated in a PCEAL-DCP clinical trial (2018-2021) to avoid possible experimental contamination effects, and 3) if no staff employed at the AL are willing to participate in the study.

Residents are ineligible if they: 1) are currently receiving hospice services because residents who receive hospice are already engaged in ACP discussions upon admission; 2) if they are discharged from assisted living to another setting (nursing home or hospital) or are admitted to hospice or have died before baseline data is collected.

Staff will be ineligible if they are not licensed nurses, administrators or dementia care coordinators of a dementia care unit or terminated/resign before baseline data is collected.

Family are ineligible if: 1) they are under 21 years of age and do not understand spoken or written English and if there is already a legal authorized representative for a resident participating in the study (one family member per resident).

\-

Where it's running

  • University of South Florida
    Tampa, Florida, United States
    Recruiting
  • University of South Florida
    Tampa, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Debra Dobbs, PhD — University of South Florida
  • Study coordinator: Debra Dobbs, PhD
  • Email: ddobbs@usf.edu
  • Phone: 813-974-5767

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.